For the Inventor, By the Inventor

Enter assignee name

Boston, MA, United States of America

Elucid Bioimaging Inc.

USPTO Granted Patents = 40

EPO Patents = 1

Trademarks = 10

Forward Citations = 1,238

Loading Chart...

Loading Chart...

20 inventors (with patents filed for the assignee):

Andrew J Buckler (40 out of 47 patents)

Xiaonan Ma (22 out of 23 patents)

David Seungwon Paik (21 out of 34 patents)

4. Keith A Moulton (21 out of 24 patents)

5. Kjell Johnson (20 out of 21 patents)

6. Mark A Buckler (13 out of 17 patents)

7. Vladimir Valtchinov (10 out of 11 patents)

8. Matthew Phillips (8 out of 8 patents)

9. Ulf Hedin (7 out of 7 patents)

10. Ljubica Matic (7 out of 7 patents)

11. Changguo Ji (5 out of 5 patents)

12. Murali Ayyapillai (5 out of 5 patents)

13. Mary E Buckler (2 out of 2 patents)

14. Anant Madabhushi (1 out of 111 patents)

15. Lawrence Martell (1 out of 1 patent)

Core Competencies:

Multi-Energy Modalities

Photon Counting

Cardiovascular Disease

Atherosclerotic Plaque

Non-Invasive Imaging

Machine Learning

Quantitative Imaging

Biological Properties

Clinical Decision Support

Soft Tissue Contrast

Risk Stratification

Pathology Analysis

40 patents: Sort by Forward Citations

1. 12749156 - Progressive exploitation of multi-energy and photon counting modalities (2026-09-29),

2. 12236595 - Characterizing permeability, neovascularization, necrosis, collagen breakdown, or inflammation (2025-02-25),

3. 12229957 - Systems and methods for diagnostics for management of cardiovascular disease patients (2025-02-18),

4. 12159406 - Determining biological properties of atherosclerotic plaque, coronary artery disease, or vasculopathy (2024-12-03),

5. 12154321 - Structured representations for interpretable machine learning applications in medical imaging (2024-11-26),

6. 12141975 - Myocardial ischemia prediction (2024-11-12),

7. 12136214 - Non-invasive imaging to inform patient care (2024-11-05),

8. 12131472 - Non-invasive imaging to determine health and disease (2024-10-29),

9. 12131471 - Longitudinal change measures for optimizing patient care (2024-10-29),

10. 12125572 - Determining likely response to anti-inflammatory and pro-resolving therapies for cardiovascular disease non-invasively (2024-10-22),

11. 12125571 - Determining likely response to glycemic treatment for cardiovascular disease non-invasively (2024-10-22),

12. 12118694 - Progressive exploitation of multi-energy and photon counting modalities (2024-10-15),

13. 12106477 - Segmenting permeability, neovascularization, necrosis, collagen breakdown, or inflammation to characterize atherosclerotic plaque, coronary artery disease, or vasculopathy (2024-10-01),

14. 12100149 - Determining likely response to combination therapies for cardiovascular disease non-invasively (2024-09-24),

15. 12073561 - Multiscale modeling to determine molecular profiles from radiology (2024-08-27),

Company Overview

Elucid Bioimaging Inc. is a Boston-based company specializing in advanced imaging solutions for the life sciences sector. The organization focuses on developing innovative software tools that enhance the visualization and analysis of complex biological data. By leveraging cutting-edge technologies, Elucid aims to facilitate breakthroughs in medical research and diagnostics, ultimately contributing to improved patient outcomes. Their expertise spans various domains, including bioinformatics and computational biology, positioning them as a key player in the evolving landscape of biomedical imaging.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

40 Patents

#57 in Boston, MA

#496 in Massachusetts

#8,635 in US

#17,087 in the World

Boston, MA, United States of America

Elucid Bioimaging Inc.

Forward Citations = 1,238

20 inventors:

Andrew J Buckler (40 out of 47 patents)

Xiaonan Ma (22 out of 23 patents)

David Seungwon Paik (21 out of 34 patents)

4. Keith A Moulton (21 out of 24 patents)

5. Kjell Johnson (20 out of 21 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Elucid Bioimaging Inc.. Retrieved from https://idiyas.com/company/elucid-bioimaging

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…